Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.120
+0.050 (4.67%)
At close: Mar 9, 2026, 4:00 PM EDT
1.090
-0.030 (-2.68%)
After-hours: Mar 9, 2026, 4:46 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $47.08 million as of March 9, 2026. Its market cap has decreased by -12.67% in one year.
Market Cap
47.08M
Enterprise Value
46.72M
1-Year Change
-12.67%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $47.08M, an increase of 2,548.42%. That is a compound annual growth rate of 163.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 44.98M | -23.66% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Klotho Neurosciences | 49.57M |
| LeonaBio | 49.48M |
| Acrivon Therapeutics | 48.91M |
| MiNK Therapeutics | 48.26M |
| Lipocine | 45.14M |
| NextCure | 43.43M |
| Apollomics | 43.05M |
| Telomir Pharmaceuticals | 42.98M |